ANTICANCER STUDIES OF ZERUMBONE-LOADED CHITOSAN-OLEIC ACID NANOPARTICLES AGAINST T47D BREAST CANCER CELLS

ERINDYAH R WIKANTYASNING; ZULFA MAZIDAH; MUHAMMAD DA’I; IKA TD KUSUMAWATI; SUPRAPTO SUPRAPTO

doi:10.22159/ijap.2024.v16s6.52790

Authors

ERINDYAH R WIKANTYASNING Faculty of Pharmacy, Universitas Muhammadiyah Surakarta, Jl. A. Yani 157 Pabelan, Kartasura, Sukoharjo-57169, Indonesia https://orcid.org/0000-0002-8997-7322
ZULFA MAZIDAH Faculty of Pharmacy, Universitas Muhammadiyah Surakarta, Jl. A. Yani 157 Pabelan, Kartasura, Sukoharjo-57169, Indonesia
MUHAMMAD DA’I Faculty of Pharmacy, Universitas Muhammadiyah Surakarta, Jl. A. Yani 157 Pabelan, Kartasura, Sukoharjo-57169, Indonesia
IKA TD KUSUMAWATI Faculty of Pharmacy, Universitas Muhammadiyah Surakarta, Jl. A. Yani 157 Pabelan, Kartasura, Sukoharjo-57169, Indonesia
SUPRAPTO SUPRAPTO Faculty of Pharmacy, Universitas Muhammadiyah Surakarta, Jl. A. Yani 157 Pabelan, Kartasura, Sukoharjo-57169, Indonesia https://orcid.org/0000-0003-4564-1779

DOI:

https://doi.org/10.22159/ijap.2024.v16s6.52790

Keywords:

Cytotoxic, Nanoparticles, Zerumbone, Chitosan, T47D cells

Abstract

Objective: The phytochemical compound zerumbone is derived from the rhizome of Zingiber zerumbet (L.) Smith. Nanotechnology-based drug delivery system employing chitosan-oleic acid nanoparticles to transport zerumbone. This study aimed to examine the cytotoxic activity of zerumbone nanoparticles against T47D breast cancer cells.

Methods: Using the ionic gelation method, zerumbone-loaded chitosan-oleic acid nanoparticles were synthesized and characterized for particle size, zeta potential, morphology, and encapsulation efficiency. Utilizing the MTT assay, flow cytometry, and confocal microscopy, the cytotoxic activity of nanoparticles was evaluated.

Results: The characterization of zerumbone nanoparticles resulted in a particle size of 116±12.04 nm, polydispersity index of 0.74±0.07 μm, and zeta potential of (+34.4) mV. HPLC analysis showed an encapsulation efficiency of 92.43±1.73%. The uptake of zerumbone-loaded chitosan-oleic acid nanoparticles into T47D cells induced higher apoptosis than the zerumbone isolate and the control nanoparticles.

Conclusion: Zerumbone-loaded chitosan-oleic acid nanoparticles showed anticancer activity against breast cancer cells T47D. Using nanoparticles as a drug delivery system would improve the clinical efficacy of anticancer treatment, which has significant implications for future cancer treatment strategies.

Downloads

Download data is not yet available.

References

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.

Waks A, Jama EW-, 2019. Breast cancer treatment: a review. jamanetwork.com. 2019;321:288–300. doi:10.1001/jama.2018.19323.

Yuliani R, Syahdeni F. Ethanolic extract of papaya leaves (Carica papaya) and its fractions have no potential cytotoxicity on T47D Cells. Pharmacon: Jurnal Farmasi Indonesia. 2020;17(1):17-23.

Nabilla II, Indrayudha P. Cytotoxic Activity of Ethanol Extract, Ethanol, Ethyl-Acetate, and Hexane Fraction of Kaffir Lime Peel (Citrus hystrix DC.) against Breast Cancer Cells T47D. Pharmacon: Jurnal Farmasi Indonesia. 2019 Jul 15;16(1):11-7.

Srivastava AK, Srivastava SK, Shah NC. Essential oil composition of Zingiber zerumbet (L.) Sm. from India. Journal of Essential Oil Research. 2000 Sep 1;12(5):595-7.

Chan M-L, Liang J-W, Hsu L-C, Chang W-L, Lee S-S, Guh J-H. Zerumbone, a ginger sesquiterpene, induces apoptosis and autophagy in human hormone-refractory prostate cancers through tubulin binding and crosstalk between endoplasmic reticulum stress and mitochondrial insult. Naunyn Schmiedebergs Arch Pharmacol. 2015;388:1223–36. doi:10.1007/s00210-015-1152-z.

Hanwar, D., Suhendi, A., Trisharyanti, I., Santoso, B., & Safitri, M. Secondary Metabolite Profile Analysis of Lempuyang Emprit Extract by Gas Chromatography-Mass Spectroscopy. University Research Colloquium. 2015;1:158-166.

Dai M, Fadhilah A, Rahmawati J, Forentin AM, Usia T, Maryati M, Saifudin A. T47D cell-inhibiting indonesian medicinal plants and active constituents of Alpinia galanga rhizome. Pharmacognosy Magazine. 2018;14(56).

Shamoto T, Matsuo Y, Shibata T, Tsuboi K, Nagasaki T, Takahashi H, Funahashi H, Okada Y, Takeyama H. Zerumbone inhibits angiogenesis by blocking NF-κB activity in pancreatic cancer. Pancreas. 2014 Apr 1;43(3):396-404.

Ibáñez MD, Sánchez-Ballester NM, Blázquez MA. Healthy zerumbone: from natural sources to strategies to improve its bioavailability and oral administration. Plants. 2022 Dec 20;12(1):5. doi:10.3390/plants12010005.

Hassan MM, Mohammed AF, Elamin KM, Devkota HP, Ohno Y, Motoyama K, Higashi T, Imai T. Improvement of pharmaceutical properties of zerumbone, a multifunctional compound, using cyclodextrin derivatives. Chemical and Pharmaceutical Bulletin. 2020 Nov 1;68(11):1117-20.

Raikar PR, Dandagi PM. Functionalized polymeric nanoparticles: a novel targeted approach for oncology care. Int J App Pharm. 2021;13(6):1-8.

Garg U, Chauhan S, Nagaich U, Jain N. Current advances in chitosan nanoparticles based drug delivery and targeting. Advanced pharmaceutical bulletin. 2019 Jun;9(2):195.

Wikantyasning ER, Andasari SD, Da’i M, Nabila A. Nanoencapsulation of zerumbone in oleic acid-modified chitosan nanoparticles. ACM International Conference Proceeding Series. 2017. 105–9.

Kesharwani SS, Bhat GJ. Formulation and nanotechnology-based approaches for solubility and bioavailability enhancement of zerumbone. Medicina. 2020;56(11):557. doi:10.3390/medicina56110557.

Miele D, Rossi S, Sandri G, Vigani B, Sorrenti M, Giunchedi P, Ferrari F, Bonferoni MC. Chitosan oleate salt as an amphiphilic polymer for the surface modification of Poly-Lactic-Glycolic Acid (PLGA) nanoparticles. preliminary studies of mucoadhesion and cell interaction properties. Marine Drugs. 2018 Nov 15;16(11):447.

Rahmawanty D, Anwar E, Bahtiar A. Utilization of cross-linked chitosan with tripolyphosphate as an excipient for haruan fish gel. J Ilm Kefarmasian Indonesia. 2015;13(1):76-81.

Kumar A, Dixit CK. Methods for characterization of nanoparticles. InAdvances in nanomedicine for the delivery of therapeutic nucleic acids 2017; 43-58.

Bhattacharjee S. DLS and zeta potential–what they are and what they are not?. Journal of controlled release. 2016 Aug 10;235:337-51.

Rahman HS, Rasedee A, Abdul AB, Zeenathul NA, Othman HH, Yeap SK, How CW, Hafiza WA. Zerumbone-loaded nanostructured lipid carrier induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in a human lymphoblastic leukemia cell line. International journal of nanomedicine. 2014 Jan 16:527-38.

Mohamad NE, Abu N, Rahman HS, Ky H, Ho WY, Lim KL, How CW, Rasedee A, Alitheen NB, Yeap SK. Nanostructured lipid carrier improved in vivo anti-tumor and immunomodulatory effect of Zerumbone in 4T1 challenged mice. RSC Advances. 2015;5(28):22066-74.

Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nature reviews Clinical oncology. 2020 Jul;17(7):395-417.

Hosseinpour M, Abdul AB, Rahman HS, Rasedee A, Yeap SK, Ahmadi N, Othman HH, Chartrand MS. Comparison of apoptotic inducing effect of zerumbone and zerumbone-loaded nanostructured lipid carrier on human mammary adenocarcinoma MDA-MB-231 cell line. Journal of Nanomaterials. 2014 Jan 1;2014:182-.